Tweet
BNP Paribas Arbitrage SA trimmed its position in MAXIMUS, Inc. (NYSE:MMS) by 56.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,743 shares of the health services provider's stock after selling 10,226 shares during the period. BNP Paribas Arbitrage SA's holdings in MAXIMUS were worth $481,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in MMS. Summit Trail Advisors LLC lifted its holdings in MAXIMUS by 5,265.8% in the 1st quarter. Summit Trail Advisors LLC now owns 843,878 shares of the health services provider's stock valued at $844,000 after purchasing an additional 828,151 shares in the last quarter. P2 Capital Partners LLC lifted its holdings in MAXIMUS by 127.1% in the 1st quarter. P2 Capital Partners LLC now owns 725,000 shares of the health services provider's stock valued at $48,387,000 after purchasing an additional 405,748 shares in the last quarter. Thompson Siegel & Walmsley LLC lifted its holdings in MAXIMUS by 49.6% in the 1st quarter. Thompson Siegel & Walmsley LLC now owns 634,146 shares of the health services provider's stock valued at $42,324,000 after purchasing an additional 210,213 shares in the last quarter. Mondrian Investment Partners LTD lifted its holdings in MAXIMUS by 27.3% in the 1st quarter. Mondrian Investment Partners LTD now owns 923,505 shares of the health services provider's stock valued at $62,457,000 after purchasing an additional 197,808 shares in the last quarter. Finally, BlackRock Inc. lifted its holdings in MAXIMUS by 2.7% in the 1st quarter. BlackRock Inc. now owns 6,852,749 shares of the health services provider's stock valued at $457,354,000 after purchasing an additional 178,208 shares in the last quarter. Institutional investors own 96.19% of the company's stock. Get MAXIMUS alerts:
In other news, Director Russell A. Beliveau sold 1,000 shares of the company's stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $61.91, for a total transaction of $61,910.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link . Also, Director Paul R. Lederer sold 7,500 shares of the company's stock in a transaction dated Tuesday, August 14th. The shares were sold at an average price of $64.05, for a total transaction of $480,375.00. Following the transaction, the director now directly owns 62,535 shares of the company's stock, valued at approximately $4,005,366.75. The disclosure for this sale can be found here . Corporate insiders own 2.48% of the company's stock.
NYSE MMS opened at $64.15 on Friday. MAXIMUS, Inc. has a 12 month low of $58.89 and a 12 month high of $72.71. The stock has a market cap of $4.07 billion, a PE ratio of 21.17, a P/E/G ratio of 2.44 and a beta of 1.16.
MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Thursday, August 9th. The health services provider reported $0.91 EPS for the quarter, beating the Zacks' consensus estimate of $0.82 by $0.09. MAXIMUS had a net margin of 9.28% and a return on equity of 21.51%. The company had revenue of $597.90 million during the quarter, compared to the consensus estimate of $591.91 million. During the same quarter in the prior year, the company posted $0.86 EPS. The company's quarterly revenue was down .4% compared to the same quarter last year. sell-side analysts forecast that MAXIMUS, Inc. will post 3.24 earnings per share for the current year.
MAXIMUS declared that its board has approved a share buyback plan on Monday, June 25th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the health services provider to reacquire up to 4.9% of its shares through open market purchases. Shares buyback plans are often an indication that the company's board of directors believes its stock is undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 31st. Stockholders of record on Wednesday, August 15th will be paid a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date of this dividend is Tuesday, August 14th. MAXIMUS's dividend payout ratio is currently 5.94%.
A number of research firms have issued reports on MMS. Zacks Investment Research upgraded shares of MAXIMUS from a "hold" rating to a "buy" rating and set a $77.00 target price on the stock in a report on Thursday, May 10th. First Analysis upgraded shares of MAXIMUS from an "equal" rating to a "weight" rating and upped their target price for the company from $73.00 to $81.00 in a report on Tuesday, May 8th. Finally, Canaccord Genuity reduced their target price on shares of MAXIMUS from $65.00 to $64.00 and set a "hold" rating on the stock in a report on Friday, May 11th. Four analysts have rated the stock with a hold rating, The stock currently has a consensus rating of "Hold" and a consensus price target of $71.00.
MAXIMUS Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews